{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:02:32Z","timestamp":1776348152320,"version":"3.51.2"},"reference-count":25,"publisher":"Pensoft Publishers","issue":"2","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p>\n                    <jats:bold>Introduction<\/jats:bold>\n                    : Although steroid-induced dyslipidemia is well-documented in adults, its impact on children remains underexplored. Given the long-term cardiovascular risks associated with dyslipidemia, understanding its link with steroid use in children is crucial.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aim<\/jats:bold>\n                    : This study aimed to evaluate the association of steroid therapy, specifically its dose, duration, and type with the development of dyslipidemia in children with chronic diseases.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and methods<\/jats:bold>\n                    : A retrospective cross-sectional study was conducted from January 2022 to January 2024 in a tertiary hospital in Medan, Indonesia. Medical records of children receiving steroid therapy for at least six weeks were reviewed. Steroid doses were converted to prednisone equivalents. Dyslipidemia was defined according to the Expert Panel Guidelines. Data distribution was assessed using normality tests and appropriate statistical tests were selected based on the distribution of each variable.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : The study included 63 children, 54 (85.7%) of whom had dyslipidemia. A significant association was found between higher steroid dose and dyslipidemia (\n                    <jats:italic>p<\/jats:italic>\n                    =0.002), especially for LDL and total cholesterol levels (\n                    <jats:italic>p<\/jats:italic>\n                    =0.005 and\n                    <jats:italic>p<\/jats:italic>\n                    =0.017, respectively). Although the association between dyslipidemia and steroid duration was borderline (\n                    <jats:italic>p<\/jats:italic>\n                    =0.050), children treated for 6\u201324 weeks exhibited significantly higher LDL (\n                    <jats:italic>p<\/jats:italic>\n                    =0.035) and total cholesterol (\n                    <jats:italic>p<\/jats:italic>\n                    =0.010) compared to those treated longer. No significant differences in lipid parameters were observed across steroid types.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Steroid use in children with chronic diseases is significantly associated with dyslipidemia. A higher steroid dose was associated with abnormal lipid profiles. These findings support the recommendation for routine lipid monitoring and careful dose consideration to help mitigate long-term cardiovascular risk.\n                  <\/jats:p>","DOI":"10.3897\/folmed.68.e171187","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:12:32Z","timestamp":1776345152000},"source":"Crossref","is-referenced-by-count":0,"title":["Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management"],"prefix":"10.3897","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5671-7946","authenticated-orcid":true,"given":"Siska Mayasari","family":"Lubis","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3314-709X","authenticated-orcid":true,"given":"Melda","family":"Deliana","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-6690","authenticated-orcid":true,"given":"Megan","family":"Quinka","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4118-9042","authenticated-orcid":true,"given":"Shofiyya","family":"Imtiyaz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"171187_B1","doi-asserted-by":"crossref","unstructured":"Ferrara G, Petrillo MG, Giani T, et al. Clinical use and molecular action of corticosteroids in the pediatric age. Int J Mol Sci 2019; 20(2):444.","DOI":"10.3390\/ijms20020444"},{"key":"171187_B2","doi-asserted-by":"crossref","unstructured":"Hales CM, Kit BK, Gu Q, et al. Trends in prescription medication use among children and adolescents-United States, 1999-2014. JAMA 2018; 319(19):2009\u201320.","DOI":"10.1001\/jama.2018.5690"},{"key":"171187_B3","doi-asserted-by":"crossref","unstructured":"Tselios K, Koumaras C, Gladman DD, et al. Dyslipidemia in systemic lupus erythematosus: just another comorbidity. Semin Arthritis Rheum 2016; 45(5):604\u201310.","DOI":"10.1016\/j.semarthrit.2015.10.010"},{"key":"171187_B4","unstructured":"Wijaya LK, Kasjmir YI, Sukmana N, et al. The proportion of dyslipidemia in systemic lupus erythematosus patient and distribution of correlated factors. Acta Med Indones 2005; 37(3):132\u201344."},{"key":"171187_B5","doi-asserted-by":"crossref","unstructured":"Buterbaugh JS. Pediatric dyslipidemia and screening recommendations. J Nurse Pract 2021; 17(10):1178\u201382.","DOI":"10.1016\/j.nurpra.2021.08.009"},{"key":"171187_B6","doi-asserted-by":"crossref","unstructured":"Sa\u0301nchez-Garci\u0301a C, Bailo\u0301n-Ortega A, Zaltzman-Girshevich S. Statins treatment in pediatric patients with steroid resistant nephrotic syndrome: two case reports. Acta Pediatr Mex 2017; 38(1):26\u201332.","DOI":"10.18233\/APM1No1pp26-321321"},{"key":"171187_B7","doi-asserted-by":"crossref","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Summary report. Pediatrics 2011; 128(Suppl 5):S213\u201356.","DOI":"10.1542\/peds.2009-2107C"},{"key":"171187_B8","doi-asserted-by":"crossref","unstructured":"Harding T, Harding A. Multiple short courses of corticosteroids in children. Aust J Gen Pract 2021; 50(3).","DOI":"10.31128\/AJGP-11-19-5164"},{"key":"171187_B9","doi-asserted-by":"crossref","unstructured":"Whittle E, Falhammar H. Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: a systematic review and meta-analysis. J Endocr Soc 2019; 3(6):1227\u201345.","DOI":"10.1210\/js.2019-00136"},{"key":"171187_B10","doi-asserted-by":"crossref","unstructured":"Rodrigues WDR, Sarni ROS, Abad TTO, et al. Lipid profile of pediatric patients with chronic rheumatic diseases: a retrospective analysis. Rev Assoc Med Bras 2020; 66(8):1093\u20139.","DOI":"10.1590\/1806-9282.66.8.1093"},{"key":"171187_B11","doi-asserted-by":"crossref","unstructured":"Jeries H, Volkova N, Grajeda-Iglesias C, et al. Prednisone and its active metabolite prednisolone attenuate lipid accumulation in macrophages. J Cardiovasc Pharmacol Ther 2020; 25(2):174\u201386.","DOI":"10.1177\/1074248419883591"},{"key":"171187_B12","doi-asserted-by":"crossref","unstructured":"Yanai H, Yoshida H. Secondary dyslipidemia: its treatments and association with atherosclerosis. J Glob Health Med 2021; 3(1):15\u201323.","DOI":"10.35772\/ghm.2020.01078"},{"key":"171187_B13","doi-asserted-by":"crossref","unstructured":"Conterato E, Machado T, De Almeida CA, et al. Leptin levels, basal metabolic rates, and insulin resistance in obese pubertal children. Int J Nutr 2020; 13:17\u201323.","DOI":"10.1055\/s-0040-1713796"},{"key":"171187_B14","doi-asserted-by":"crossref","unstructured":"Schou AJ, Wolthers OD. Serum fructosamine, total cholesterol, and high-density lipoprotein in children with asthma during glucocorticoid treatment. ISRN Allergy 2011; 2011:295124.","DOI":"10.5402\/2011\/295124"},{"key":"171187_B15","doi-asserted-by":"crossref","unstructured":"Huang S, Zhang Z, Cui Y, et al. Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus. Clin Rheumatol 2023; 42(6):1565\u201372.","DOI":"10.1007\/s10067-023-06539-2"},{"key":"171187_B16","unstructured":"Dolatabadi A, Mahboubi M. A study of the influence of dexamethasone on lipid profile and enzyme lactate dehydrogenase. J Med Life 2015; 8(Spec Iss 3):72\u20136."},{"key":"171187_B17","doi-asserted-by":"crossref","unstructured":"Atik N, Hayati RU, Hamijoyo L. Correlation between steroid therapy and lipid profile in systemic lupus erythematosus patients. Open Access Rheumatol 2020; 12:41\u20136.","DOI":"10.2147\/OARRR.S245662"},{"key":"171187_B18","doi-asserted-by":"crossref","unstructured":"Basu B, Babu BG, Bhattacharyya S. Managing hypertriglyceridemia in children with systemic lupus erythematosus: two sides of the same coin. Reumatol Clin 2018; 14(1):46\u20138.","DOI":"10.1016\/j.reuma.2016.09.003"},{"key":"171187_B19","unstructured":"Malynda M, Vitria R, Rochmah N. The effect of high-dose methylprednisolone on HbA1c, HOMA-IR, fasting glucose and lipid profile in child patients with lupus nephritis. Int J Prog Res Sci Eng 2022; 3(4):35\u201343."},{"key":"171187_B20","unstructured":"Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J 2014; 14(2):203\u20137."},{"key":"171187_B21","doi-asserted-by":"crossref","unstructured":"Heidari S, Fathi M, Aminzadeh M, et al. Effects of long-term inhaled corticosteroid therapy on metabolic and anthropometric parameters in pediatric patients with asthma. Curr Res Med Rev 2025; 21(2): 159\u201365.","DOI":"10.2174\/011573398X321966240816091814"},{"key":"171187_B22","doi-asserted-by":"crossref","unstructured":"Lau KK, Tancredi DJ, Perez RV, et al. Unusual pattern of dyslipidemia in children receiving steroid minimization immunosuppression after renal transplantation. Clin J Am Soc Nephrol 2010; 5(8):1506\u201312.","DOI":"10.2215\/CJN.08431109"},{"key":"171187_B23","doi-asserted-by":"crossref","unstructured":"Bertoni C, Mazzocchi A, Leone L, et al. Cardiovascular risk and inflammation in a population with autoimmune diseases: a narrative review. Front Immunol 2024; 15:1380372.","DOI":"10.3389\/fimmu.2024.1380372"},{"key":"171187_B24","doi-asserted-by":"crossref","unstructured":"Mitra S, Nandi M, Mahato S, et al. Changes in biomarkers of lipid in juvenile idiopathic arthritis and its association with various disease parameters: a 6-month follow-up study. Int J Contemp Pediatr 2024; 11(6):736\u201343.","DOI":"10.18203\/2349-3291.ijcp20241357"},{"key":"171187_B25","doi-asserted-by":"crossref","unstructured":"Mogensen PR, Grell K, Schmiegelow K, et al. Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia. PLoS One 2020; 15(4):e0231209.","DOI":"10.1371\/journal.pone.0231209"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/171187\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/171187\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=171187&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:12:43Z","timestamp":1776345163000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/171187\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,16]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.68.e171187","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"e171187"}}